Skip to main content

Replimune Group, Inc. insider trading

REPLNASDAQ
$13.15+0.08 (+0.61% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+181.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • PAPhilip Astley-SparkeDirector1.446%of company
  • SPSushil PatelChief Executive Officer0.7516%of company
  • KXKonstantinos XynosChief Medical Officer0.238%of company
  • ELEmily Luisa HillChief Financial Officer0.2291%of company
  • CSChristopher SarchiChief Commercial Officer0.1921%of company
  • ASAndrew SchwendenmanChief Accounting Officer0.1055%of company
  • KDKapil DhingraDirector0.00%of company
  • FBFelix BakerDirectorNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
REPLEmily Luisa HillChief Financial OfficerOpen market sell$132K-4.1%$14.28$132KAug 17, 2026Aug 19, 2026
REPLSushil PatelChief Executive OfficerOpen market sell$510K-5.3%$12.97$510KAug 10, 2026Aug 12, 2026
REPLEmily Luisa HillChief Financial OfficerOpen market sell$148K-4.8%$12.97$148KAug 10, 2026Aug 12, 2026
REPLKonstantinos XynosChief Medical OfficerOpen market sell$148K-4.9%$12.97$148KAug 10, 2026Aug 12, 2026
REPLAndrew SchwendenmanChief Accounting OfficerOpen market sell$99K-7.1%$12.97$99KAug 10, 2026Aug 12, 2026
REPLChristopher SarchiChief Commercial OfficerOpen market sell$111K-6.2%$9.24$111KJun 1, 2026Jun 3, 2026
REPLKonstantinos XynosChief Medical OfficerOpen market sell$71.2K-5.6%$5.08$71.2KMay 18, 2026May 20, 2026
REPLAndrew SchwendenmanChief Accounting OfficerOpen market sell$40.1K-6.9%$5.08$40.1KMay 18, 2026May 20, 2026
REPLChristopher SarchiChief Commercial OfficerOpen market sell$43.8K-4.3%$5.08$43.8KMay 18, 2026May 20, 2026
REPLPhilip Astley-SparkeDirectorOpen market sell$89.7K-1.2%$5.08$89.7KMay 18, 2026May 20, 2026
REPLSushil PatelChief Executive OfficerOpen market sell$190K-4.8%$5.08$190KMay 18, 2026May 20, 2026
REPLEmily Luisa HillChief Financial OfficerOpen market sell$39.7K-3.2%$5.08$39.7KMay 18, 2026May 20, 2026
REPLChristopher SarchiChief Commercial OfficerOpen market sell$52.1K-4.1%$8.01$52.1KApr 2, 2026Apr 6, 2026
REPLSushil PatelChief Executive OfficerOpen market sell$111K-2.9%$11.13$111KDec 2, 2025Dec 4, 2025
REPLChristopher SarchiChief Commercial OfficerOpen market sell$47.4K-4.1%$9.10$47.4KNov 17, 2025Nov 19, 2025
REPLKonstantinos XynosChief Medical OfficerOpen market sell$66K-4.9%$9.10$66KNov 17, 2025Nov 19, 2025
End of history · 16 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.